Interpace OTC Stock Valuation

What is the value of Interpace Biosciences today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Interpace Biosciences, is its stock price multiplied by the total number of shares outstanding, calculating Interpace Biosciences' enterprise value requires a different approach. It uses Interpace Biosciences' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Interpace Biosciences Tangible Asset Value is projected to decrease significantly based on the last few years of reporting. The past year's Tangible Asset Value was at 22.71 Million.
Interpace Biosciences regular Real Value cannot be determined due to lack of data. The prevalent price of Interpace Biosciences is $0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Our model calculates the value of Interpace Biosciences from evaluating the firm fundamentals such as Current Valuation of 14.07 M, return on asset of (0.26) %, and Return On Equity of (2.85) % as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage purchasing undervalued assets and exiting overvalued assets since, at some point, asset prices and their ongoing real values will come together.
  
Interpace Biosciences Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Interpace Biosciences's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Interpace Most Recent Valuation Data

Beta
0.79
Fiscal Year End
December
Enterprise Value
14.1 M
net Debt
6.4 M
accounts Payable
2.7 M
non Currrent Assets Other
160 K
Undervalued
Today 0.00
Please note that Interpace Biosciences' price fluctuation is out of control at this time. Calculation of the real value of Interpace Biosciences is based on 3 months time horizon. Increasing Interpace Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Interpace Biosciences is useful when determining the fair value of the Interpace otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Interpace Biosciences. Since Interpace Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Interpace OTC Stock. However, Interpace Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
0.00
Real Value
14.57
Upside
Estimating the potential upside or downside of Interpace Biosciences helps investors to forecast how Interpace otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Interpace Biosciences more accurately as focusing exclusively on Interpace Biosciences' fundamentals will not take into account other important factors:
Earnings
Estimates (1)
LowProjected EPSHigh
-2.61-2.61-2.61
Details
Hype
Prediction
LowEstimated ValueHigh
0.000.0014.57
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Interpace Biosciences' intrinsic value based on its ongoing forecasts of Interpace Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Interpace Biosciences' closest peers. When choosing an evaluation method for Interpace Biosciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Interpace Biosciences Investments

95,263.16

Interpace Valuation Drivers Correlation

Many accounts on the financial statements of Interpace Biosciences are highly interrelated and sometimes correlated. Consequently, when conducting Interpace's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Interpace
Click cells to compare fundamentals

Interpace Valuation Trend

Knowing Interpace Biosciences' actual value is paramount for traders to make sound investment determinations. Interpace Biosciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Interpace Biosciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Interpace Biosciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Interpace Market Cap

Interpace Biosciences is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 221.46 Billion. Interpace Biosciences adds roughly 4.91 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Revenue  Valuation  Workforce  Total debt

Interpace Biosciences Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Interpace Biosciences's current stock value. Our valuation model uses many indicators to compare Interpace Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Interpace Biosciences competition to find correlations between indicators driving Interpace Biosciences's intrinsic value. More Info.
Interpace Biosciences is rated second overall in price to book category among related companies. It is rated fifth overall in net asset category among related companies making up about  3,828,458  of Net Asset per Price to Book. The current year Average Assets is expected to grow to about 51.2 M. The current year Tangible Asset Value is expected to grow to about 28.4 M. Comparative valuation analysis is a catch-all model that can be used if you cannot value Interpace Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Interpace Biosciences' OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Interpace Biosciences' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Interpace Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Interpace Biosciences and how it compares across the competition.

About Interpace Biosciences Valuation

The otc valuation mechanism determines the current worth of Interpace Biosciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Interpace Biosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Interpace Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Interpace Biosciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Interpace Biosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Interpace Biosciences. We calculate exposure to Interpace Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Interpace Biosciences's related companies.
Fiscal Year End
December
Industry
Diagnostics & Research
Concentration
Health Care Services
Full Time Employees
147.0
Service Category
Health Care Providers & Services
Employer Id Number
22-2919486
Last ReportedProjected for 2022
Gross Profit17.9 M15.2 M
Profit Margin(64.02) (69.07) 

Interpace Biosciences Current Valuation Indicators

Valuation refers to the process of determining the present value of Interpace Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Interpace we look at many different elements of the entity such as Interpace's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Interpace Biosciences' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Interpace Biosciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Interpace Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Interpace Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Interpace Biosciences' worth.
Please see Risk vs Return Analysis. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for analysis

When running Interpace Biosciences price analysis, check to measure Interpace Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Interpace Biosciences is operating at the current time. Most of Interpace Biosciences' value examination focuses on studying past and present price action to predict the probability of Interpace Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Interpace Biosciences' price. Additionally, you may evaluate how the addition of Interpace Biosciences to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Please note, there is a significant difference between Interpace Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Interpace Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpace Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.